The capacity of numerous bacterial species to tolerate antibiotics and other toxic compounds arises in part from the activity of energy-dependent transporters. In Gram-negative bacteria, many of these transporters form multicomponent 'pumps' that span both inner and outer membranes and are driven energetically by a primary or secondary transporter component 1-7 . A model system for such a pump is the acridine resistance complex of Escherichia coli 1 . This pump assembly comprises the outer-membrane channel TolC, the secondary transporter AcrB located in the inner membrane, and the periplasmic AcrA, which bridges these two integral membrane proteins. The AcrAB-TolC efflux pump is able to transport vectorially a diverse array of compounds with little chemical similarity, thus conferring resistance to a broad spectrum of antibiotics. Homologous complexes are found in many Gram-negative species, including in animal and plant pathogens. Crystal structures are available for the individual components of the pump 2-7 and have provided insights into substrate recognition, energy coupling and the transduction of conformational changes associated with the transport process. However, how the subunits are organized in the pump, their stoichiometry and the details of their interactions are not known. Here we present the pseudo-atomic structure of a complete multidrug efflux pump in complex with a modulatory protein partner 8 from E. coli. The model defines the quaternary organization of the pump, identifies key domain interactions, and suggests a cooperative process for channel assembly and opening. These findings illuminate the basis for drug resistance in numerous pathogenic bacterial species.
The capacity of numerous bacterial species to tolerate antibiotics and other toxic compounds arises in part from the activity of energy-dependent transporters. In Gram-negative bacteria, many of these transporters form multicomponent 'pumps' that span both inner and outer membranes and are driven energetically by a primary or secondary transporter component 1-7 . A model system for such a pump is the acridine resistance complex of Escherichia coli 1 . This pump assembly comprises the outer-membrane channel TolC, the secondary transporter AcrB located in the inner membrane, and the periplasmic AcrA, which bridges these two integral membrane proteins. The AcrAB-TolC efflux pump is able to transport vectorially a diverse array of compounds with little chemical similarity, thus conferring resistance to a broad spectrum of antibiotics. Homologous complexes are found in many Gram-negative species, including in animal and plant pathogens. Crystal structures are available for the individual components of the pump 2-7 and have provided insights into substrate recognition, energy coupling and the transduction of conformational changes associated with the transport process. However, how the subunits are organized in the pump, their stoichiometry and the details of their interactions are not known. Here we present the pseudo-atomic structure of a complete multidrug efflux pump in complex with a modulatory protein partner 8 from E. coli. The model defines the quaternary organization of the pump, identifies key domain interactions, and suggests a cooperative process for channel assembly and opening. These findings illuminate the basis for drug resistance in numerous pathogenic bacterial species.
A small, 49-residue protein, AcrZ, has recently been identified in genetic screens as a binding partner of AcrB that affects substrate preference 8 . A mutant strain of E. coli lacking AcrZ is sensitive to some, but not all, antibiotics that are exported by the AcrAB-TolC pump. AcrZ is conserved in many enterobacterial lineages, suggesting that modulation by small proteins may be a recurring theme in the RND protein family to which AcrB belongs.
To investigate their interaction, AcrB was co-expressed with AcrZ carrying a carboxy-terminal histidine tag. The partner proteins copurified through Ni 21 affinity and size-exclusion chromatography (Extended Data Fig. 1a ), and co-crystals of the AcrBZ complex were obtained. Additionally, co-crystals were obtained of a ternary complex formed with a designed ankyrin-repeat protein (DARPin)-used in previous studies for co-crystallization with AcrB 9 -that diffracted better than co-crystals of the AcrBZ complex alone (Extended Data Fig. 1b and Extended Data Table 1 ). Electron density corresponding to AcrZ was apparent in the early, unbiased maps (Extended Data Fig. 2) . AcrZ folds into a long, predominantly hydrophobic a-helix that fits into a wide groove in the transmembrane domain of AcrB (Fig. 1a, b and Extended Data Fig. 2) . The AcrBZ complex overlays well with the previously reported structure of AcrB bound to another potential partner, YajC 10 (Extended Data Fig. 3a ). The helical axis of AcrZ is inclined by nearly 45u with respect to the normal vector of the lipid bilayer, and although this is an unusual extent of inclination for a transmembrane a-helix, it optimizes the interfacial complementarity. The interfacial residues are well conserved among the identified homologues of AcrZ, suggesting that analogous interactions are likely to occur for other RND family proteins (Extended Data Fig. 3b , c). We were able to model AcrZ residues 1-46, revealing that the amino terminus is in the periplasm and the C terminus is in the cytoplasm, where it interacts with the hydrophilic surface of AcrB, near the membrane (Fig. 1b ). It seems possible that the reported effects of AcrZ on drug sensitivity 8 might originate from the allosteric modulation of AcrB activity by AcrZ.
To stabilize the complete pump assembly, constructs were prepared in which the components were fused (Extended Data Fig. 4a, b ). On the basis of the crystal structure of the AcrBZ complex, a construct was designed in which AcrA is fused through a flexible linker to the N terminus of AcrZ, which was predicted to leave the individual structures unperturbed and to permit localization of AcrA to the periplasm while allowing AcrZ to cross the inner membrane with the correct topology and preserving its interactions with AcrB. This fusion harbours a histidine tag on the C terminus of AcrZ to facilitate Ni 21 affinity purification of the fusion protein. In a second engineered construct, we identified a loop in the periplasmic domain of AcrB where AcrA could be inserted with flexible linkers. Both the AcrA-AcrZ-His 5 and AcrA-AcrB fusions were stable during overexpression and purification.
At present, there is debate about the compositional stoichiometry of the AcrAB-TolC pump, with evidence favouring a 3:6:3 ratio for AcrB: AcrA:TolC 11-16 . To enable the assembly of such a complex, we explored the co-expression of the fusion pairs AcrA-AcrB and AcrA-AcrZ-His 5 . In the course of isolating the co-expressed recombinant proteins, we observed that the AcrA-AcrZ-His 5 fusion co-purified with both the AcrA-AcrB fusion and endogenous TolC. We subsequently designed co-expression vectors comprising fusion proteins of AcrA-AcrB, AcrA-AcrZ-His 5 and TolC, and found that the proteins remained associated during purification (Extended Data Fig. 4c ). Assays of minimum inhibitory concentration (MIC) and drug efflux using the AcrAB and AcrAZ fusion proteins show that the engineered pump retains partial activity (Extended Data Fig. 5 ).
The assembly was further purified by the GraFix method 17 , and analysis of the fractions by negative staining electron microscopy readily led to the identification of drumstick-shaped particles that matched the expected size and shape of the pump (Extended Data Fig. 6a ). The crosslinked particles were subsequently imaged using cryo-electron microscopy (cryo-EM), which shows images of isolated and aggregated particles ( Fig. 2a ). Initial three-dimensional reconstruction was carried out using EMAN2 (ref. 18) without any imposed symmetry (Extended Data Fig. 6b ), which suggested the presence of at least three-fold symmetry. As TolC and AcrB are known to be homotrimers, a subsequent three-fold symmetry enforced map was independently produced (Extended Data Fig. 6c ). We then used RELION software 19 to refine the particle classification and orientation determination, which improved the map greatly. The resolution of the final map was estimated to be ,16 Å (Extended Data Fig. 7a ). This map was validated by a tilt-pair analysis (Extended Data Fig. 7b ), which is considered to be best practice for assessing the correctness of a lowresolution cryo-EM map 20 .
The quality of the final cryo-EM map was sufficient to permit docking of the crystal structures of TolC, AcrA and the AcrBZ complex with only small movements in the flexible linker regions between the domains of AcrA ( Fig. 2b and Methods). After sequential fitting of AcrA, AcrBZ and TolC into the cryo-EM map, the final model has good agreement with the density envelope ( Fig. 2b , c and Extended Data Fig. 8a ). The transmembrane portion of TolC is enclosed in a torus that resembles the detergent shell observed for aquaporin in the same detergent used in this study, namely n-dodecyl-b-D-maltopyranoside (DDM) 21 . The detergent also forms a layer around the transmembrane portion of AcrB (Fig. 2b, c) .
One salient observation of our model is that there is no direct interaction between TolC and AcrB in the assembly, in contradiction to earlier models 3, 22 . Instead, the two proteins are bridged in the periplasm entirely through AcrA. This is consistent with in vivo crosslinking and pull-down assays, which indicated that AcrA interacts with AcrB and TolC independently, whereas no interaction was observed between AcrB and TolC 23 . Our model also accounts for thermodynamic measurements, which suggest that the pairwise interactions of AcrA-AcrB and AcrA-TolC occur spontaneously, whereas that between AcrB and TolC does not 23 . The organization of the AcrA-TolC subassembly is in agreement with the dimensions of the homologous MexA-OprM complex from Pseudomonas aeruginosa 24, 25 .
Our model shows that the assembly comprises an AcrB trimer, an AcrA hexamer and a TolC trimer. This is in accord with the 3:6 stoichiometry of the homologous CusA-CusB heavy-metal efflux complex 15 . The hexameric assembly of AcrA resembles that of the homologous MacA 16 (Fig. 3a, b) . The a-helical coiled coils (or 'hairpins') of AcrA pack into a cylinder that interacts with the periplasmic ends of the a-helical coiled coils portion of TolC. As TolC has an internal structural repeat, there are six quasi-equivalent contact surfaces that interact with the AcrA hairpins ( Fig. 3a and Extended Data Fig. 8b ).
The membrane-proximal domain and b-barrel domain of AcrA are involved in defined interactions with AcrB ( Fig. 3a ). One protomer of AcrA bridges the upper regions of subdomains PC1, PC2 and DC of AcrB (protomer 1 in Fig. 3a) ; this interaction is similar to that between CusA and CusB ( Fig. 3c ). However, the adjacent protomer of AcrA (protomer 2 in Fig. 3a ) interacts with AcrB in a different manner: here, the membrane-proximal domain of AcrA shifts towards the PN2 subdomain of AcrB so that only the upper regions of PN2 and DN contact AcrA. The lipoyl domains of AcrA principally interact with each other to form a channel that is closed to the periplasm and make no predicted interactions with either AcrB or TolC.
The side-by-side packing of the b-barrel, lipoyl and a-helical hairpin domains of the six AcrA protomers generates a funnel-like structure with a sealed central channel along the three-fold axis. A chamber is formed by the b-barrel and lipoyl domains of AcrA, and the bottom of the chamber opens into the funnel of AcrB. The chamber is partially constricted near the middle of the lipoyl domain ( Fig. 2c and Extended Data Fig. 8a ). It then continues to a channel created by the helical hairpin domains, with a cogwheel shape at the end of these domains, like that of MacA ( Fig. 3a, b ). The modelled docking of the membraneproximal domain of AcrA onto the surface of AcrB is consistent with the disruptive behaviour of mutants at that interface 26, 27 .
A cross-section through the reconstruction reveals a conduit that is open to the cell exterior and runs from the transmembrane b-barrel of White circles indicate particles with long axis almost normal to the viewing plane; black circles show particles with the long axis parallel to the viewing plane. Scale bar, 50 nm. b, The reconstructed map and pseudo-atomic model. TolC and AcrBZ are homotrimers that engage six protomers of AcrA to form an assembly with a protein mass of 771 kDa. AcrA has a composite structure of four linearly discontinuous domains connected by flexible linkers 4 (see also Fig. 3a ). c, A slice through the reconstruction and model, which shows the continuous conduit that runs from the AcrB funnel through the TolC porin domain. IM, inner membrane; OM, outer membrane.
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TolC, through the TolC periplasmic domain, and continues all the way to the funnel-shaped canyon in the periplasmic domain of AcrB (Fig. 2c) . The cross-section indicates that the channel is sealed off from the periplasm and cytoplasm, and the components in the pseudoatomic model shown in Fig. 2b pack efficiently to leave no gaps. The conduit is the likely exit pathway for efflux of substrates, which will be delivered into this chamber through successive opening and closing of ligand-binding pockets in AcrB, adjacent to the apex of the funnelshaped periplasmic canyon.
In isolation, TolC assumes a 'closed' resting state in which its periplasmic domain tapers to a near close, but to be accommodated in the continuous channel seen in the cryo-EM model, TolC must switch to an 'open' state 28, 29 (Fig. 2c and Extended Data Fig. 8b ). The opening of TolC must result from its direct interactions with the a-helical hairpins of AcrA. In this scenario, AcrB provides a platform for the proper assembly of hexameric AcrA suitable for presentation to TolC and opening of the channel. The AcrAB-TolC assembly forms in vivo without the requirement for substrates or proton-motive force 30 , suggesting that exogenous energy may not be required to open TolC in the context of the assembled pump. It seems likely that TolC remains open throughout the transport cycle, and we propose that the dilation of TolC from the closed to the open state is driven by both chelate cooperativity (due to the hexameric organization of AcrA) and allosteric cooperativity (associated with the breaking of interprotomer interactions in TolC).
The structure of the efflux pump presented here is likely to be similar to homologous assemblies in pathogenic species that infect humans such as Vibrio cholerae, P. aeruginosa, Neisseria gonorrhoeae and Salmonella enterica. The question arises as to how it might be feasible to counter the actions of drug efflux in the treatment of bacterial infections. It seems paradoxical that a compound might exist that would achieve this, when the pump is well crafted to handle diverse compounds. Perhaps the protein-protein contacts that mediate the assembly might be favourable targets for such approaches.
METHODS SUMMARY
Recombinant proteins were engineered with histidine tags, overexpressed in E. coli and purified chromatographically. The AcrBZ and AcrBZ-DARPin complexes were crystallized by vapour diffusion and diffraction data were collected at the Diamond Light Source synchrotron facility. The crystal structure was solved using molecular replacement and refined. Freshly prepared specimens of the AcrABZ-TolC complex were applied to glycerol-glutaraldehyde gradients with ultracentrifugation 17 . The fractions were analysed by electron microscopy after either negative staining or rapid freezing under hydrated conditions. Individual particles were chosen from the cryo-EM images and were used for two-dimensional projection class averages and three-dimensional image reconstruction 18, 19 . For in vivo activity tests of the engineered AcrABZ-TolC pump, expression vectors for the fusion proteins and controls were transformed into deletion strains. MICs were evaluated in the presence of antibiotics and efflux assays were conducted on fluorescent substrates.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Construction of vectors for overexpression of AcrBZ and AcrABZ-TolC complex.
The acrZ gene was generated by PCR from genomic DNA of E. coli W3110 strain using primers AcrZNcoI_F: 59-TGGCCATGGGCTTAGAGTTATTAAAAAGT CTGGTATTCGCCGTAATCATGG-39 and AcrZHis 5 SalI_R: 59-GACGTCGACT CAGTGGTGGTGGTGGTGATGATTTTGTCCGGGCTGGTCTTTTTTACC-39. The pRSFDuet-1-acrZ His5 vector was constructed by subcloning the fragment of acrZ-His 5 , bounded by NcoI and SalI sites, into the multiple cloning site (MCS) of expression vector pRSFDuet-1.
The pET21a-acrB His6 vector was constructed by subcloning the fragment of acrB, bounded by NdeI and XhoI sites, into the MCS of expression vector pET21a. The vector pET21a-acrB DHis was constructed by site-directed mutagenesis using pET21a-acrB His6 as a template and primers AcrB_CF: 59-TGAAGATATCGAGCACAGC CATACTGTCGATTGAGATCCGGCTGCTAACAAAGCCC-39 and AcrB_CR: 59-GGGCTTTGTTAGCAGCCGGATCTCAATCGACAGTATGGCTGTGCTC GATATCTTCA-39.
The acrA gene was amplified using primers AcrANcoI_F: 59-TGGCCATGG GCAACAAAAACAGAGGGTTTACGCCTCTGGCG-39 and AcrAGSx3_R: 59-T GGCCATGGATCCGCCGCCACCAGAGCCACCACCGCCGCTCCCACCGCCA CCAGACTTGGACTGTTCAGGCTGAGCACC-39, to add a poly-GlySer linker to the C terminus and a NcoI site at both ends. The NcoI-bounded acrA-polyGlySer was subcloned into the NcoI site of pRSFDuet-1-acrZ His5 , resulting in the construct pRSFDuet-1-acrA-polyGlySer-acrZ His5 . The tolC gene was amplified using primers TolCinf_F: 59-AAGGAGATATACATATGAAGAAATTGCTCCCCATTCTTA TCGGCC-39 and TolC1392inf_R: 59-TTGAGATCTGCCATATGTCAATCAG CAATAGCATTCTGTTCCGGCGT-39. The PCR product was then inserted into the NdeI site of pRSFDuet-1-acrA-polyGlySer-acrZ His5 using the In-Fusion cloning method (Clontech), generating the construct pRSFDuet-1-acrA-polyGlySer-acrZ His5 -tolC 1392 .
A BamHI site was inserted into acrB by site-directed mutagenesis using pET21a-acrB DHis as a template and primers AcrB_D328F: 59-CTGAAAATTGTT TACCCATAGACGGATCCACCACGCCGTTCGTGAAA-39 and AcrB_D328R: 59-TTTCACGAACGGCGTGGTGGATCCGTCGTATGGGTAAACAATTTTCA G-39, resulting in the construct pET21a-acrB DHis BamHI 328 . The acrA gene was amplified using primers AcrA_25GSF: 59-GGATCCGGTGGGAGCGGTGGCGG CGGTAGTGGCGGTGGTGGCTCTTGTGACGACAAACAGGCCCAACAAGG-39 and AcrAGSx3_R2: 59-GGATCCGCCGCCACCAGAGCCACCACCGCCGCTCCCA CCGCCACCAGACTTGGACTGTTCAGGCTGAGCACC-39, to add a poly-GlySer linker to both ends of acrA. The resulting DNA fragment was amplified again using primers AcrA Infusion_Forward: 59-CCCATACGACGGATCCGGTGGGAGCG GTGGCGGCGGTA-39 and AcrA Infusion_Reverse: 59-ACGGCGTGGTGGAT CCGCCGCCACCAGAGCCACCACC-39. The DNA fragment was then inserted into the BamHI site of pET21a-acrB DHis BamHI 328 using the In-Fusion cloning method, generating the construct pET21a-acrB 328 -polyGlySer-acrA-polyGlySer-acrB 329 . Overexpression and purification of the AcrBZ and the AcrBZ-DARPin complexes. The constructs pET21a-acrB DHis and pRSFDuet-1-acrZ His5 were transformed into E. coli strain C43(DE3) DacrAB 31 . The C-terminal histidines of AcrB were substituted to prevent nonspecific association with the metal affinity matrix. Cells were grown in 23 YT medium with 100 mg ml 21 carbenicillin and 50 mg ml 21 kanamycin at 37 uC until the culture reached an absorbance, at 600 nm, of 0.5-0.6 and was then induced by the addition of 0.5 mM isopropyl 1-thio-b-D-galactopyranoside (IPTG) at 18 uC overnight. Cell pellets were resuspended in lysis buffer (400 mM sodium chloride, 20 mM Tris-HCl, pH 8.0) with 1 tablet per 50 ml EDTAfree protease inhibitor cocktail tablets, 5 U ml 21 DNase I and 5 mg ml 21 lysozyme, and the mixture was stirred at 4 uC for 1 h to digest the cell wall. The cells were lysed using a homogenizer (EmulsiFlex) at 15,000 psi for eight passages. Cell debris was pelleted by centrifugation at 9,000g for 30 min. Cellular membrane was pelleted by ultracentrifugation at 125,755g for 3 h.
Membrane pellets were resuspended in lysis buffer with protease inhibitors and were solubilized by adding 1.5% DDM and stirring at 4 uC for 3 h. Debris was pelleted by ultracentrifugation at 125,755g for 30 min. Imidazole was added to the membrane solution to a final concentration of 10 mM. Histidine-tagged AcrBZ complex was purified by nickel affinity chromatography using a HiTrap chelating column (GE Healthcare Life Sciences) equilibrated with GF buffer 1 (400 mM sodium chloride, 20 mM Tris-HCl, pH 8.0, 0.05% DDM) containing 20 mM imidazole. The column was washed with 50 mM and 75 mM imidazole added to GF buffer 1, respectively. Purified AcrBZ complex was eluted with 500 mM imidazole in GF buffer 1, concentrated and loaded onto a Superose 6 column equilibrated with GF buffer 1. Fractions containing purified AcrBZ complex were pooled and concentrated to 15-20 mg ml 21 using a Vivaspin concentrator (MWCO 5 100 kDa) and dialysed overnight against sample buffer (10 mM HEPES pH 7.5, 50 mM sodium chloride, 0.03% DDM) using a 100 kDa MWCO dialysis membrane to decrease the detergent concentration.
The DARPin gene was synthesized and protein was overexpressed and purified as described 9 . Purified DARPin and AcrBZ complex were mixed at a molar ratio of 1:2 (AcrBZ monomer:DARPin monomer). The mixture was diluted with GF buffer 2 (20 mM Tris-HCl, pH 7.5, 150 mM sodium chloride, 0.03% DDM) to a concentration of 2-3 mg ml 21 , incubated at 4 uC overnight, then concentrated to 0.5 ml using a Vivaspin concentrator (MWCO 5 100 kDa) and loaded onto a Superose 6 column equilibrated with GF buffer 2. Fractions containing purified AcrBZ-DARPin complex were pooled and concentrated to 15-20 mg ml 21 using a Vivaspin concentrator (MWCO 5 100 kDa) and dialysed overnight against sample buffer using a 100 kDa MWCO dialysis membrane; the final concentration was 10-15 mg ml 21 . Crystallization of AcrBZ and AcrBZ-DARPin. The AcrBZ and AcrBZ-DARPin complexes were diluted to 10 mg ml 21 using sample buffer. 9 mM n-octyl-b-Dthioglucopyranoside (90 mM) was mixed with the AcrBZ complex before the crystallization trials. The AcrBZ crystals were grown at 20 uC using the hanging-droplet vapour diffusion method by mixing 4 ml of AcrBZ complex with 2 ml of reservoir solution (100 mM tricine, pH 7.4, 50 mM lithium sulphate, 5 mM cadmium chloride hydrate, 7% PEG 3000, 10% glycerol). The AcrBZ-DARPin complex was incubated with puromycin at 1 mM for 3 h at 4 uC before crystallization trials. Crystals were grown at 20 uC using the sitting-droplet vapour diffusion method by mixing 400 nl of AcrBZ-DARPin complex with 200 nl of reservoir solution (100 mM HEPES, pH 7.5, 10 mM MgCl 2 and 12% (w/v) PEG 3350). Crystals appeared 24 h after setting up the crystallization trials and reached maximal size in 1 week. The crystals were transferred briefly into reservoir solution supplemented with 25% glycerol as cryoprotectant before flash freezing in liquid nitrogen. Crystallographic data collection and structure refinement. Data sets were collected using beamlines I04-1 and I24 at the Diamond Light Source. The diffraction data were processed using X-ray Detector Software (XDS) 32 and scaled using SCALA 33 . Structures were solved by molecular replacement using Phaser with chain A of AcrB (PDB accession 4DX5) 7 as a search model and refined using Crystallography and NMR System (CNS) 34, 35 , PHENIX 36 and REFMAC5 (ref. 37 ) with reference structure restraints 38 . Coot was used for modelling 39 . Data collection and refinement parameters are presented in Extended Data Table 1 .
Both the AcrBZ and AcrBZ-DARPin complexes crystallized in space group R32. The asymmetric unit is occupied by one protomer of AcrB and one protomer of AcrZ. Maps calculated from molecular replacement using only the AcrB protomer revealed clear electron density for AcrZ in both complexes (see Extended Data Fig. 2) . For the AcrBZ-DARPin complex, unbiased density was also present that could fit the DARPin model. Density was also apparent that matched the modelled detergent and acyl chains in the 1.9 Å resolution structure of E. coli AcrB 7 (PDB accession 4DX5). These were included in the model, as well as additional acyl chains that were located mostly in the intra-protomer space in the transmembrane region of AcrB. For both AcrBZ and AcrBZ-DARPin complexes, the AcrB homotrimer is formed through crystallographic symmetry, so that any potential non-equivalence of the protomers is consequently lost. Expression and purification of the efflux pump assembly. The constructs pET21a-acrB 328 -polyGlySer-acrA-polyGlySer-acrB 329 and pRSFDuet-1-acrA-polyGlySer-acrZ His5 -tolC 1392 were transformed into E. coli strain C43(DE3)DacrAB. The procedure for overexpression and purification of AcrABZ-TolC is similar to that of AcrBZ, with minor modifications, as follows. Cells were induced with 0.15 mM IPTG at 20 uC overnight, harvested and resuspended in lysis buffer 2 (20 mM Tris-HCl, pH 7.5, 400 mM NaCl) for membrane preparation. Cellular membrane was solubilized with 1.5% DDM in lysis buffer 2. The AcrABZ-TolC complex purified by nickel affinity chromatography was loaded onto a Superose 6 column equilibrated with GF buffer 3 (50 mM HEPES pH 7.5, 400 mM NaCl, 0.03% DDM). Fractions containing purified AcrABZ-TolC complex were pooled and concentrated to 1 mg ml 21 using a Vivaspin column (MWCO 5 100 kDa). Transport assays. Transport activity was measured as described 40 with some modifications. Plasmids were propagated in the triple knockout E. coli strain MCDtolCDacrAB 23,41 , a derivative of E. coli MC1061 converted to a (DE3) lysogen. All experiments used basal levels of protein expression without induction with IPTG. Cells were grown in LB-Broth Miller medium (Formedium) containing the appropriate antibiotic(s) with shaking at 37 uC until an OD 660 nm of 0.5 was reached. The cells were harvested by centrifugation at 3,000g for 10 min at 4 uC, then washed three times by resuspension in 50 mM potassium phosphate buffer, pH 7.0, containing 5 mM MgSO 4 and sedimented by centrifugation at 3,000g for 10 min at 4 uC. The cells were then resuspended in the same buffer to an OD 660 nm of 0.5 and incubated for 3 min at room temperature (25 uC) in the presence of 25 mM glucose to energize the cells. The fluorescence measurement was started, and 60 s later 2 mM ethidium bromide or 0.25 mM trimethylammonium-diphenylhexatriene (TMA-DPH) was added. The fluorescence was followed as a function of time in a PerkinElmer LS 55B fluorimeter. Excitation and emission wavelengths and excitation and emission slit widths were 500, 580, 5 and 10 nm respectively for ethidium bromide; and 350, 425, 5 and 5 nm respectively for TMA-DPH. Initial substrate transport rates were determined between 85 to 185 s and 75 to 95 s for ethidium bromine and TMA-DPH, respectively. Assays were performed twice per day for three separate days, with different cell preparations used each day. GraFix preparation of the efflux pump assembly. The GraFix procedure for the AcrABZ-TolC complex was carried out as described 17, 42 . Gradients for GraFix were generated by mixing GraFix buffer 1 (50 mM HEPES, pH 7.5, 400 mM NaCl, 0.03% w/v DDM, 10% v/v glycerol) and GraFix buffer 2 (50 mM HEPES, pH 7.5, 400 mM NaCl, 0.03% w/v DDM, 30% v/v glycerol, 0.15% v/v glutaraldehyde) using a gradient mixer (Gradient Master 107, BioComp Instruments), following the manufacturer's recommendations for determining the parameters. 100 pmol of AcrABZ-TolC complex was loaded onto the top of the buffering cushion. Ultracentrifugation was carried out at 111,845g, 4 uC for 18 h (SW60 rotor, Beckmann). After centrifugation, the gradients were fractionated at 4 uC by using a capillary to pump the gradient out from bottom to top, taking fractions of 200 ml. The same fractions from different centrifuge tubes were pooled, respectively. Glycine (1 M, pH 7.5) was added to the fractions to a final concentration of 80 mM to quench further crosslinking, and the mixtures were concentrated to 200 ml using a Vivaspin concentrator (MWCO 5 100 kDa). The concentrated protein samples were diluted to 1 ml using GF buffer 3, and were concentrated to 100 ml again to decrease the concentration of glycerol. The AcrABZ-TolC samples were flash frozen in liquid nitrogen and stored at 280 uC. Negative-stain electron microscopy. Continuous carbon electron microscopy grids (Agar Scientific) were glow discharged. Sample adsorption was achieved by placing the grid carbon-side down on a 10 ml drop of protein solution at a concentration of approximately 10 mg ml 21 . Adsorption times were determined empirically. After blotting to dryness, the grid was washed by placing it onto a drop of deionized H 2 O for 5 s, blotted dry, and then repeated. The protein was stained by transferring the grid to a drop of 2% w/v uranyl acetate for 30 s, then dried and stored at room temperature. The sample was then imaged at 320,000 magnification and 120 keV in a FEI Tecnai G 2 microscope at the Multi Imaging Centre, University of Cambridge. Cryo-EM specimen preparation and data collection. Samples were embedded in vitreous ice as per the following method. A 2.0 ml aliquot at approximately 2 mg ml 21 was applied onto holey carbon film supported by a 200-mesh R1.2/1.3 Quantifoil grid (Quantifoil) that had been previously washed and glow discharged. The grid was blotted and rapidly frozen in liquid ethane using a Vitrobot IV (FEI) with constant temperature and humidity during the process of blotting, and the grid was stored in liquid nitrogen before imaging. All grids were screened on a JEM3200FSC cryo-electron microscope (JEOL) operated at 300 kV, spot size 2, condenser aperture 70 mm, objective aperture 60 mm, and energy slit of the in-column filter of 20 eV. Images were recorded with a direct detection device (DDD) (DE-12 3kx4k camera, Direct Electron, LP) operating in movie mode at a recording rate of 25 raw frames per second. A magnification of 320,000 (corresponding to a calibrated sampling of 2.47 Å per pixel) and a dose rate of 25 electrons s 21 Å 22 were used to acquire data for each specimen area with a total exposure time of 2 s. A total of 1,281 DDD images using movie frame mode were collected with a defocus range of 2-4 mm. Cryo-EM data processing and resolution evaluation. Particle images were manually boxed with the EMAN2 program e2boxer.py 18 with a box size of 256 3 256 pixels using the averaged sum of 48 raw frames per specimen area. The final frame average was computed from averages of every five consecutive frames to correct for the specimen movement during exposure similar to the procedure previously described 43 . The particle intensity in each frame was weighted according to a radiation damage model (courtesy of B. Bammes). Defocus of the particles in each frame average was determined by EMAN2 program e2ctf.py 44 . The first reconstruction was done without any symmetry imposition or any initial model, using EMAN2 (ref. 18 ). We started with 12,000 particle images and 8,400 particle images were selected manually according to the similarity in appearance to the class averages. The first map without any symmetry imposition appeared to have a six-fold symmetry (Extended Data Fig. 6b ), which justified applying a three-fold symmetry enforcement (Extended Data Fig. 6c ). The symmetry-free and symmetry-imposed maps look similar except for a slight difference in contrast. Then, we used RELION 19 to perform two additional steps of particle orientation refinement of the 8,400 selected particle images. Using the EMAN2-generated map (Extended Data Fig. 6c ), low-pass filtered to 60 Å , we performed a particle orientation refinement by RELION with search angle of 7.5 degrees for 14 iterations and subsequently with an angular sampling of 1.8 degrees for 11 iterations. The resolution of the resulting map is 21 Å based on 0.143 FSC criterion (Extended Data Fig. 7a ). Next, this map was sharpened 18 and low-pass filtered to 30 Å before preforming a second round of particle orientation refinement by RELION with an angular sampling of 1.8 degrees for 8 iterations. The resolution of the final map is estimated to be 16 Å by the 0.143 FSC criterion (Extended Data Fig. 7a ). The final map displayed in Fig. 2b, c has been sharpened and filtered to 16 Å .
Cryo-EM map tilt-pair validation. To further validate the cryo-EM map (Fig. 2b) , we carried out tilt-pair analysis 20 of the AcrABZ-TolC complex. Pairs of images were recorded on a JEM2010F electron microscope at a magnification of 330,000 with a relative tilt of 10 degrees, along a known axis. Each pair of particle images thus has a known experimental relative tilt. We then determined the orientation of each particle in the pair using the final reconstructed map as a reference. The relative tilt between these computed orientations should match the experimental tilt. Each point in Extended Data Fig. 7b represents one pair of particles in the tilt pair, with radius representing computed relative tilt, and azimuth representing tilt angle. Ideally all points would lie in exactly the same location; however, there is always some uncertainty in orientation determination, exacerbated in this case by radiation damage in the second image of the tilt pair and the strong pseudo hexagonal symmetry. As previously observed 45 , if the map is incorrect, the relative angles will not correlate at all, and produce a nearly random distribution over the sphere. A clear cluster as observed in our case is an indication of successful validation, and our computed tilt angle of 10.44 degrees is a good match with the microscope setting of 10 degrees. The presence of some points at mirrored positions across the origin is an indication of weak handedness in the map, meaning that the map and its mirror image are difficult to distinguish at this resolution in some orientations. Model docking. The merged map was low-pass filtered before rigid body docking of crystal structures using Coot and UCSF Chimera 46 (http://www.cgl.ucsf.edu/ chimera). The symmetric partially opened model of TolC was used to prepare a fully opened model (PDB accession 2XMN) 47 . A homologous model of the inner sets of coiled coils was devised based on the outer sets of coiled coils, which was used to replace the inner sets of coiled coils. The uncoiling movement of the inner sets of coiled coils produced a fully opened TolC 2 .
The b-barrel domain, lipoyl domain and a-helical hairpin domain of each AcrA protomer were modelled with chain C in the asymmetric unit of the crystal structure of AcrA (PDB accession 2F1M) 4 . A homology model of the membrane proximal domain of AcrA was devised based on the structure of MexA (PDB accession 2V4D) 22 .
The individual domains of AcrA were fitted into the cryo-EM reconstruction using Coot, according to the features of the cryo-EM map and prior knowledge of the homohexameric MacA assembly (PDB accessions 3FPP and 4DK0). The closedstate TolC (PDB accession 1EK9), partially opened (PDB accession 2XMN) and fully opened model of TolC were separately fitted into the cryo-EM reconstruction, respectively. The AcrBZ trimer, the TolC trimer and the AcrA hexamer were treated as individual rigid bodies. These three rigid bodies were automatically fitted into the cryo-EM map by sequential fitting using Chimera. The AcrABZ-TolC model generated by Chimera was slightly adjusted manually to optimize the local fit into the density using Coot 39 . The cross-correlation coefficient for fitting the AcrABZ-open-TolC model to the map is 0.924 and was calculated using the 'fit in map' function of Chimera.
